enGene Therapeutics Inc. Insider Trading
ENGN
Insiders bought 10K on the open market and sold nothing.
Get an email when ENGN's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Sep 22 | William Grossman Interim Chief Medical Officer | Bought | 5,102 | $1.97 | 10K | New | Form 4 |
- Sep 22William GrossmanInterim Chief Medical Officer · bought 5,102 at $1.9710KNew position
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biotechnology · Pick stocks to compare with ENGN
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ENGN
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.